{
  "company_id": "jnj",
  "company_name": "Johnson & Johnson",
  "generated_at": "2026-02-05T05:37:19Z",
  "kpis": {
    "assets_total": 44,
    "assets_with_trials": 20,
    "trials_total": 263
  },
  "top_assets": [
    {
      "asset_id": 64,
      "asset_name": "Azacitidine",
      "highest_stage": "Registration",
      "linked_trials_count": 5,
      "indications": [
        {
          "indication": "Cancer (ATLAS) intravesical delivery system) Invasive Bladder Cancer BCG",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Cancer (ATLAS) intravesical delivery system) Invasive Bladder Cancer BCG",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 45,
      "asset_name": "ypertension75mg",
      "highest_stage": "Registration",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "pipeline is based on the current status of these this information. *AC Immune ACI-35.030. of rilpivirine and cabotegravir: ViiV Healthcare; Tau Immunotherapy: AC Immune SA; Biotech; AKEEGA: TESARO, an oncology- iPSC-derived chimeric antigen receptor",
          "stage": "Registration",
          "therapeutic_area": null
        },
        {
          "indication": "pipeline is based on the current status of these this information. *AC Immune ACI-35.030. of rilpivirine and cabotegravir: ViiV Healthcare; Tau Immunotherapy: AC Immune SA; Biotech; AKEEGA: TESARO, an oncology- iPSC-derived chimeric antigen receptor",
          "stage": "Registration",
          "therapeutic_area": null
        },
        {
          "indication": "pipeline is based on the current status of these this information. *AC Immune ACI-35.030. of rilpivirine and cabotegravir: ViiV Healthcare; Tau Immunotherapy: AC Immune SA; Biotech; AKEEGA: TESARO, an oncology- iPSC-derived chimeric antigen receptor",
          "stage": "Registration",
          "therapeutic_area": null
        }
      ]
    },
    {
      "asset_id": 69,
      "asset_name": "(PROTOSTAR)",
      "highest_stage": "Registration",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Arthritis Hemolytic Anemia (ENERGY) Alloimmune Thrombocytopenia",
          "stage": "Registration",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Arthritis Hemolytic Anemia (ENERGY) Alloimmune Thrombocytopenia",
          "stage": "Registration",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 14,
      "asset_name": "(ORIGAMI-2)",
      "highest_stage": "Registration",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Multiple Myeloma CD38 exposed",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 23,
      "asset_name": "(MajesTEC-4)",
      "highest_stage": "Registration",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Acute Myeloid Leukemia (cAMeLot-",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Acute Myeloid Leukemia (cAMeLot-",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Acute Myeloid Leukemia (cAMeLot-",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Acute Myeloid Leukemia (cAMeLot-",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Acute Myeloid Leukemia (cAMeLot-",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Acute Myeloid Leukemia (cAMeLot-",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 25,
      "asset_name": "TREMFYA",
      "highest_stage": "Phase 3",
      "linked_trials_count": 29,
      "indications": [
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 10,
      "asset_name": "ERLEADA",
      "highest_stage": "Phase 3",
      "linked_trials_count": 24,
      "indications": [
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 57,
      "asset_name": "nipocalimab",
      "highest_stage": "Phase 3",
      "linked_trials_count": 11,
      "indications": [
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 12,
      "asset_name": "TALVEY + TECVAYLI",
      "highest_stage": "Phase 3",
      "linked_trials_count": 7,
      "indications": [
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory (MonumenTAL-6)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory (MonumenTAL-6)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 26,
      "asset_name": "icotrokinra",
      "highest_stage": "Phase 3",
      "linked_trials_count": 4,
      "indications": [
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease (ICONIC-CD)",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease (ICONIC-CD)",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 19,
      "asset_name": "bleximenib",
      "highest_stage": "Phase 3",
      "linked_trials_count": 4,
      "indications": [
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 5,
      "asset_name": "RYBREVANT",
      "highest_stage": "Phase 3",
      "linked_trials_count": 4,
      "indications": [
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 37,
      "asset_name": "SPRAVATO",
      "highest_stage": "Phase 3",
      "linked_trials_count": 3,
      "indications": [
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 22,
      "asset_name": "JNJ-7446",
      "highest_stage": "Phase 3",
      "linked_trials_count": 2,
      "indications": [
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 1,
      "asset_name": "INLEXZO (gemcitabine",
      "highest_stage": "Phase 3",
      "linked_trials_count": 2,
      "indications": [
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive (SunRISe-3)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive (SunRISe-3)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 43,
      "asset_name": "SIRTURO",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "L e p r o s y under review by regulatory bodies. Inclusion in the & Johnson assumes no obligation to update Long acting HIV injectible treatment regimen",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies. Inclusion in the & Johnson assumes no obligation to update Long acting HIV injectible treatment regimen",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies. Inclusion in the & Johnson assumes no obligation to update Long acting HIV injectible treatment regimen",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        }
      ]
    },
    {
      "asset_id": 62,
      "asset_name": "Leprosy",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "under review by regulatory bodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "under review by regulatory bodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "under review by regulatory bodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        }
      ]
    },
    {
      "asset_id": 28,
      "asset_name": "JNJ-4804 Co-antibody",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 21,
      "asset_name": "JNJ-4681",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 66,
      "asset_name": "JNJ-3413",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Lymphoma",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lymphoma",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 20,
      "asset_name": "JNJ-2175",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 60,
      "asset_name": "JNJ-1887 sCD59",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 33,
      "asset_name": "ITI-1284",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Alzheimer's Disease-Related",
          "stage": "Phase 1",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "with Generalized Anxiety",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 9,
      "asset_name": "Bleximenib",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 63,
      "asset_name": "(amivantamab)",
      "highest_stage": "Phase 2",
      "linked_trials_count": 27,
      "indications": [
        {
          "indication": "Cancer (ORIGAMI-5)",
          "stage": "Phase 2",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Cancer (ORIGAMI-5)",
          "stage": "Phase 2",
          "therapeutic_area": "Oncology"
        }
      ]
    }
  ],
  "recent_changes": [
    {
      "event_type": "trials_ingested",
      "created_at": "2026-02-05 05:37:13.288885",
      "occurred_at": "2026-02-05 05:37:13.288885",
      "payload": {
        "trials_seen": 191,
        "inserted": 0,
        "updated": 191,
        "status_changed": 0,
        "bad_aliases": 0
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:01.826948",
      "occurred_at": "2026-02-05 05:37:01.826948",
      "payload": {
        "nct_id": "NCT04150887",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:01.372578",
      "occurred_at": "2026-02-05 05:37:01.372578",
      "payload": {
        "nct_id": "NCT04023526",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:00.467968",
      "occurred_at": "2026-02-05 05:37:00.467968",
      "payload": {
        "nct_id": "NCT04883619",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:00.455271",
      "occurred_at": "2026-02-05 05:37:00.455271",
      "payload": {
        "nct_id": "NCT06533098",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:00.441869",
      "occurred_at": "2026-02-05 05:37:00.441869",
      "payload": {
        "nct_id": "NCT06449651",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:00.428455",
      "occurred_at": "2026-02-05 05:37:00.428455",
      "payload": {
        "nct_id": "NCT05379634",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:00.414773",
      "occurred_at": "2026-02-05 05:37:00.414773",
      "payload": {
        "nct_id": "NCT05327114",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:37:00.401094",
      "occurred_at": "2026-02-05 05:37:00.401094",
      "payload": {
        "nct_id": "NCT04119050",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:59.332763",
      "occurred_at": "2026-02-05 05:36:59.332763",
      "payload": {
        "nct_id": "NCT06878404",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:59.314560",
      "occurred_at": "2026-02-05 05:36:59.314560",
      "payload": {
        "nct_id": "NCT06807424",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:58.030827",
      "occurred_at": "2026-02-05 05:36:58.030827",
      "payload": {
        "nct_id": "NCT03767075",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:58.017242",
      "occurred_at": "2026-02-05 05:36:58.017242",
      "payload": {
        "nct_id": "NCT06816992",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:58.004929",
      "occurred_at": "2026-02-05 05:36:58.004929",
      "payload": {
        "nct_id": "NCT06632236",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.993013",
      "occurred_at": "2026-02-05 05:36:57.993013",
      "payload": {
        "nct_id": "NCT07062354",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.980738",
      "occurred_at": "2026-02-05 05:36:57.980738",
      "payload": {
        "nct_id": "NCT05117931",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.967844",
      "occurred_at": "2026-02-05 05:36:57.967844",
      "payload": {
        "nct_id": "NCT05299125",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.954855",
      "occurred_at": "2026-02-05 05:36:57.954855",
      "payload": {
        "nct_id": "NCT04988295",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.931499",
      "occurred_at": "2026-02-05 05:36:57.931499",
      "payload": {
        "nct_id": "NCT04077463",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.908328",
      "occurred_at": "2026-02-05 05:36:57.908328",
      "payload": {
        "nct_id": "NCT05845671",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.894756",
      "occurred_at": "2026-02-05 05:36:57.894756",
      "payload": {
        "nct_id": "NCT06385080",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.879765",
      "occurred_at": "2026-02-05 05:36:57.879765",
      "payload": {
        "nct_id": "NCT06667076",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.865183",
      "occurred_at": "2026-02-05 05:36:57.865183",
      "payload": {
        "nct_id": "NCT06750094",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.847770",
      "occurred_at": "2026-02-05 05:36:57.847770",
      "payload": {
        "nct_id": "NCT06120140",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.831167",
      "occurred_at": "2026-02-05 05:36:57.831167",
      "payload": {
        "nct_id": "NCT06532032",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.810076",
      "occurred_at": "2026-02-05 05:36:57.810076",
      "payload": {
        "nct_id": "NCT05498428",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.794274",
      "occurred_at": "2026-02-05 05:36:57.794274",
      "payload": {
        "nct_id": "NCT06662786",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.776192",
      "occurred_at": "2026-02-05 05:36:57.776192",
      "payload": {
        "nct_id": "NCT05488314",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.762684",
      "occurred_at": "2026-02-05 05:36:57.762684",
      "payload": {
        "nct_id": "NCT02609776",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.747342",
      "occurred_at": "2026-02-05 05:36:57.747342",
      "payload": {
        "nct_id": "NCT05908734",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.734472",
      "occurred_at": "2026-02-05 05:36:57.734472",
      "payload": {
        "nct_id": "NCT05601973",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.721448",
      "occurred_at": "2026-02-05 05:36:57.721448",
      "payload": {
        "nct_id": "NCT05388669",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.700012",
      "occurred_at": "2026-02-05 05:36:57.700012",
      "payload": {
        "nct_id": "NCT04538664",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.678363",
      "occurred_at": "2026-02-05 05:36:57.678363",
      "payload": {
        "nct_id": "NCT04487080",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.651735",
      "occurred_at": "2026-02-05 05:36:57.651735",
      "payload": {
        "nct_id": "NCT05663866",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.204973",
      "occurred_at": "2026-02-05 05:36:57.204973",
      "payload": {
        "nct_id": "NCT06505369",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.188653",
      "occurred_at": "2026-02-05 05:36:57.188653",
      "payload": {
        "nct_id": "NCT06100237",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.173670",
      "occurred_at": "2026-02-05 05:36:57.173670",
      "payload": {
        "nct_id": "NCT06353022",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.156964",
      "occurred_at": "2026-02-05 05:36:57.156964",
      "payload": {
        "nct_id": "NCT05849610",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.142403",
      "occurred_at": "2026-02-05 05:36:57.142403",
      "payload": {
        "nct_id": "NCT05469893",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.119922",
      "occurred_at": "2026-02-05 05:36:57.119922",
      "payload": {
        "nct_id": "NCT07107529",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.107069",
      "occurred_at": "2026-02-05 05:36:57.107069",
      "payload": {
        "nct_id": "NCT06993675",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.094639",
      "occurred_at": "2026-02-05 05:36:57.094639",
      "payload": {
        "nct_id": "NCT05572229",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.081759",
      "occurred_at": "2026-02-05 05:36:57.081759",
      "payload": {
        "nct_id": "NCT06649695",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.069879",
      "occurred_at": "2026-02-05 05:36:57.069879",
      "payload": {
        "nct_id": "NCT07258511",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.053134",
      "occurred_at": "2026-02-05 05:36:57.053134",
      "payload": {
        "nct_id": "NCT05695508",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.039622",
      "occurred_at": "2026-02-05 05:36:57.039622",
      "payload": {
        "nct_id": "NCT07030517",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.028495",
      "occurred_at": "2026-02-05 05:36:57.028495",
      "payload": {
        "nct_id": "NCT05231629",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:57.010829",
      "occurred_at": "2026-02-05 05:36:57.010829",
      "payload": {
        "nct_id": "NCT07105059",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.999089",
      "occurred_at": "2026-02-05 05:36:56.999089",
      "payload": {
        "nct_id": "NCT04722146",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.985499",
      "occurred_at": "2026-02-05 05:36:56.985499",
      "payload": {
        "nct_id": "NCT03145181",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.972694",
      "occurred_at": "2026-02-05 05:36:56.972694",
      "payload": {
        "nct_id": "NCT05083169",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.957334",
      "occurred_at": "2026-02-05 05:36:56.957334",
      "payload": {
        "nct_id": "NCT05338775",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.942087",
      "occurred_at": "2026-02-05 05:36:56.942087",
      "payload": {
        "nct_id": "NCT04586426",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.928948",
      "occurred_at": "2026-02-05 05:36:56.928948",
      "payload": {
        "nct_id": "NCT05552222",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.912154",
      "occurred_at": "2026-02-05 05:36:56.912154",
      "payload": {
        "nct_id": "NCT06425991",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.899642",
      "occurred_at": "2026-02-05 05:36:56.899642",
      "payload": {
        "nct_id": "NCT04696809",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.887936",
      "occurred_at": "2026-02-05 05:36:56.887936",
      "payload": {
        "nct_id": "NCT04108195",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.874330",
      "occurred_at": "2026-02-05 05:36:56.874330",
      "payload": {
        "nct_id": "NCT05572515",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.858880",
      "occurred_at": "2026-02-05 05:36:56.858880",
      "payload": {
        "nct_id": "NCT04557098",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.452247",
      "occurred_at": "2026-02-05 05:36:56.452247",
      "payload": {
        "nct_id": "NCT05767359",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.423083",
      "occurred_at": "2026-02-05 05:36:56.423083",
      "payload": {
        "nct_id": "NCT06577025",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.394485",
      "occurred_at": "2026-02-05 05:36:56.394485",
      "payload": {
        "nct_id": "NCT06550895",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.371745",
      "occurred_at": "2026-02-05 05:36:56.371745",
      "payload": {
        "nct_id": "NCT04133636",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:56.346269",
      "occurred_at": "2026-02-05 05:36:56.346269",
      "payload": {
        "nct_id": "NCT05421663",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:54.372309",
      "occurred_at": "2026-02-05 05:36:54.372309",
      "payload": {
        "nct_id": "NCT05243797",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:54.004811",
      "occurred_at": "2026-02-05 05:36:54.004811",
      "payload": {
        "nct_id": "NCT06852222",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.988859",
      "occurred_at": "2026-02-05 05:36:53.988859",
      "payload": {
        "nct_id": "NCT04811560",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.974873",
      "occurred_at": "2026-02-05 05:36:53.974873",
      "payload": {
        "nct_id": "NCT05453903",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.961036",
      "occurred_at": "2026-02-05 05:36:53.961036",
      "payload": {
        "nct_id": "NCT07295951",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.590585",
      "occurred_at": "2026-02-05 05:36:53.590585",
      "payload": {
        "nct_id": "NCT07164443",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.576231",
      "occurred_at": "2026-02-05 05:36:53.576231",
      "payload": {
        "nct_id": "NCT07082920",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.563565",
      "occurred_at": "2026-02-05 05:36:53.563565",
      "payload": {
        "nct_id": "NCT07319871",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.550974",
      "occurred_at": "2026-02-05 05:36:53.550974",
      "payload": {
        "nct_id": "NCT06095089",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:53.537980",
      "occurred_at": "2026-02-05 05:36:53.537980",
      "payload": {
        "nct_id": "NCT07225946",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:51.781894",
      "occurred_at": "2026-02-05 05:36:51.781894",
      "payload": {
        "nct_id": "NCT07276399",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:51.768063",
      "occurred_at": "2026-02-05 05:36:51.768063",
      "payload": {
        "nct_id": "NCT07227025",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:51.754874",
      "occurred_at": "2026-02-05 05:36:51.754874",
      "payload": {
        "nct_id": "NCT05379595",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:50.000140",
      "occurred_at": "2026-02-05 05:36:50.000140",
      "payload": {
        "nct_id": "NCT06103760",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:49.625826",
      "occurred_at": "2026-02-05 05:36:49.625826",
      "payload": {
        "nct_id": "NCT07053345",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:46.437356",
      "occurred_at": "2026-02-05 05:36:46.437356",
      "payload": {
        "nct_id": "NCT06477783",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:46.424833",
      "occurred_at": "2026-02-05 05:36:46.424833",
      "payload": {
        "nct_id": "NCT07110844",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:45.690461",
      "occurred_at": "2026-02-05 05:36:45.690461",
      "payload": {
        "nct_id": "NCT02354014",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.973695",
      "occurred_at": "2026-02-05 05:36:44.973695",
      "payload": {
        "nct_id": "NCT05858632",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.960541",
      "occurred_at": "2026-02-05 05:36:44.960541",
      "payload": {
        "nct_id": "NCT04645355",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.948522",
      "occurred_at": "2026-02-05 05:36:44.948522",
      "payload": {
        "nct_id": "NCT06563323",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.934716",
      "occurred_at": "2026-02-05 05:36:44.934716",
      "payload": {
        "nct_id": "NCT06586281",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.922101",
      "occurred_at": "2026-02-05 05:36:44.922101",
      "payload": {
        "nct_id": "NCT05004727",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.908530",
      "occurred_at": "2026-02-05 05:36:44.908530",
      "payload": {
        "nct_id": "NCT05669833",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.895137",
      "occurred_at": "2026-02-05 05:36:44.895137",
      "payload": {
        "nct_id": "NCT07255781",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.881575",
      "occurred_at": "2026-02-05 05:36:44.881575",
      "payload": {
        "nct_id": "NCT06651489",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.867822",
      "occurred_at": "2026-02-05 05:36:44.867822",
      "payload": {
        "nct_id": "NCT04929210",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.848528",
      "occurred_at": "2026-02-05 05:36:44.848528",
      "payload": {
        "nct_id": "NCT05049798",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.822992",
      "occurred_at": "2026-02-05 05:36:44.822992",
      "payload": {
        "nct_id": "NCT06663332",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.810275",
      "occurred_at": "2026-02-05 05:36:44.810275",
      "payload": {
        "nct_id": "NCT05347095",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.795316",
      "occurred_at": "2026-02-05 05:36:44.795316",
      "payload": {
        "nct_id": "NCT07141004",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.783559",
      "occurred_at": "2026-02-05 05:36:44.783559",
      "payload": {
        "nct_id": "NCT06408935",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.768635",
      "occurred_at": "2026-02-05 05:36:44.768635",
      "payload": {
        "nct_id": "NCT03451851",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.740069",
      "occurred_at": "2026-02-05 05:36:44.740069",
      "payload": {
        "nct_id": "NCT04882098",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.720765",
      "occurred_at": "2026-02-05 05:36:44.720765",
      "payload": {
        "nct_id": "NCT04936308",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.118958",
      "occurred_at": "2026-02-05 05:36:44.118958",
      "payload": {
        "nct_id": "NCT04496063",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.105900",
      "occurred_at": "2026-02-05 05:36:44.105900",
      "payload": {
        "nct_id": "NCT05387031",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.086063",
      "occurred_at": "2026-02-05 05:36:44.086063",
      "payload": {
        "nct_id": "NCT02103361",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.074119",
      "occurred_at": "2026-02-05 05:36:44.074119",
      "payload": {
        "nct_id": "NCT05299931",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.062488",
      "occurred_at": "2026-02-05 05:36:44.062488",
      "payload": {
        "nct_id": "NCT03941132",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.049629",
      "occurred_at": "2026-02-05 05:36:44.049629",
      "payload": {
        "nct_id": "NCT06807593",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.038371",
      "occurred_at": "2026-02-05 05:36:44.038371",
      "payload": {
        "nct_id": "NCT05083182",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.024424",
      "occurred_at": "2026-02-05 05:36:44.024424",
      "payload": {
        "nct_id": "NCT07303686",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:44.011769",
      "occurred_at": "2026-02-05 05:36:44.011769",
      "payload": {
        "nct_id": "NCT07310095",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.998232",
      "occurred_at": "2026-02-05 05:36:43.998232",
      "payload": {
        "nct_id": "NCT05092269",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.972549",
      "occurred_at": "2026-02-05 05:36:43.972549",
      "payload": {
        "nct_id": "NCT04372108",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.959445",
      "occurred_at": "2026-02-05 05:36:43.959445",
      "payload": {
        "nct_id": "NCT07245394",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.540128",
      "occurred_at": "2026-02-05 05:36:43.540128",
      "payload": {
        "nct_id": "NCT05778097",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.526386",
      "occurred_at": "2026-02-05 05:36:43.526386",
      "payload": {
        "nct_id": "NCT03899077",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.512786",
      "occurred_at": "2026-02-05 05:36:43.512786",
      "payload": {
        "nct_id": "NCT03141671",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.496865",
      "occurred_at": "2026-02-05 05:36:43.496865",
      "payload": {
        "nct_id": "NCT04295447",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.481683",
      "occurred_at": "2026-02-05 05:36:43.481683",
      "payload": {
        "nct_id": "NCT04812366",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.464819",
      "occurred_at": "2026-02-05 05:36:43.464819",
      "payload": {
        "nct_id": "NCT03902951",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.442160",
      "occurred_at": "2026-02-05 05:36:43.442160",
      "payload": {
        "nct_id": "NCT03903835",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.424322",
      "occurred_at": "2026-02-05 05:36:43.424322",
      "payload": {
        "nct_id": "NCT02913196",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.409665",
      "occurred_at": "2026-02-05 05:36:43.409665",
      "payload": {
        "nct_id": "NCT05191680",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.396110",
      "occurred_at": "2026-02-05 05:36:43.396110",
      "payload": {
        "nct_id": "NCT06067269",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.367924",
      "occurred_at": "2026-02-05 05:36:43.367924",
      "payload": {
        "nct_id": "NCT04181203",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.344463",
      "occurred_at": "2026-02-05 05:36:43.344463",
      "payload": {
        "nct_id": "NCT06274047",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.331260",
      "occurred_at": "2026-02-05 05:36:43.331260",
      "payload": {
        "nct_id": "NCT05960578",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.305001",
      "occurred_at": "2026-02-05 05:36:43.305001",
      "payload": {
        "nct_id": "NCT07002320",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.291485",
      "occurred_at": "2026-02-05 05:36:43.291485",
      "payload": {
        "nct_id": "NCT04662580",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.277465",
      "occurred_at": "2026-02-05 05:36:43.277465",
      "payload": {
        "nct_id": "NCT05818683",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.262313",
      "occurred_at": "2026-02-05 05:36:43.262313",
      "payload": {
        "nct_id": "NCT03523442",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.249839",
      "occurred_at": "2026-02-05 05:36:43.249839",
      "payload": {
        "nct_id": "NCT05901649",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.236412",
      "occurred_at": "2026-02-05 05:36:43.236412",
      "payload": {
        "nct_id": "NCT04557059",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.221517",
      "occurred_at": "2026-02-05 05:36:43.221517",
      "payload": {
        "nct_id": "NCT05884398",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.207400",
      "occurred_at": "2026-02-05 05:36:43.207400",
      "payload": {
        "nct_id": "NCT03767244",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.191668",
      "occurred_at": "2026-02-05 05:36:43.191668",
      "payload": {
        "nct_id": "NCT04267887",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.161594",
      "occurred_at": "2026-02-05 05:36:43.161594",
      "payload": {
        "nct_id": "NCT04325828",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:43.146962",
      "occurred_at": "2026-02-05 05:36:43.146962",
      "payload": {
        "nct_id": "NCT04108208",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:40.590068",
      "occurred_at": "2026-02-05 05:36:40.590068",
      "payload": {
        "nct_id": "NCT04951622",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:38.820934",
      "occurred_at": "2026-02-05 05:36:38.820934",
      "payload": {
        "nct_id": "NCT05265273",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:38.806492",
      "occurred_at": "2026-02-05 05:36:38.806492",
      "payload": {
        "nct_id": "NCT06251076",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:37.929979",
      "occurred_at": "2026-02-05 05:36:37.929979",
      "payload": {
        "nct_id": "NCT05197049",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:36.602316",
      "occurred_at": "2026-02-05 05:36:36.602316",
      "payload": {
        "nct_id": "NCT05528510",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:36.107660",
      "occurred_at": "2026-02-05 05:36:36.107660",
      "payload": {
        "nct_id": "NCT07217587",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.649314",
      "occurred_at": "2026-02-05 05:36:35.649314",
      "payload": {
        "nct_id": "NCT03218488",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.636172",
      "occurred_at": "2026-02-05 05:36:35.636172",
      "payload": {
        "nct_id": "NCT07196748",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.620844",
      "occurred_at": "2026-02-05 05:36:35.620844",
      "payload": {
        "nct_id": "NCT05912517",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.602927",
      "occurred_at": "2026-02-05 05:36:35.602927",
      "payload": {
        "nct_id": "NCT05242471",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.576191",
      "occurred_at": "2026-02-05 05:36:35.576191",
      "payload": {
        "nct_id": "NCT05923073",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.520733",
      "occurred_at": "2026-02-05 05:36:35.520733",
      "payload": {
        "nct_id": "NCT05242484",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.484528",
      "occurred_at": "2026-02-05 05:36:35.484528",
      "payload": {
        "nct_id": "NCT07196722",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.457320",
      "occurred_at": "2026-02-05 05:36:35.457320",
      "payload": {
        "nct_id": "NCT06559306",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.439579",
      "occurred_at": "2026-02-05 05:36:35.439579",
      "payload": {
        "nct_id": "NCT07227454",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.425761",
      "occurred_at": "2026-02-05 05:36:35.425761",
      "payload": {
        "nct_id": "NCT06741969",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.408579",
      "occurred_at": "2026-02-05 05:36:35.408579",
      "payload": {
        "nct_id": "NCT06934226",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:35.391484",
      "occurred_at": "2026-02-05 05:36:35.391484",
      "payload": {
        "nct_id": "NCT06260163",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:34.022580",
      "occurred_at": "2026-02-05 05:36:34.022580",
      "payload": {
        "nct_id": "NCT04033445",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:33.986022",
      "occurred_at": "2026-02-05 05:36:33.986022",
      "payload": {
        "nct_id": "NCT03466411",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:25.021228",
      "occurred_at": "2026-02-05 05:36:25.021228",
      "payload": {
        "nct_id": "NCT07219212",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:25.006374",
      "occurred_at": "2026-02-05 05:36:25.006374",
      "payload": {
        "nct_id": "NCT04892173",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:24.616502",
      "occurred_at": "2026-02-05 05:36:24.616502",
      "payload": {
        "nct_id": "NCT07029776",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:24.601855",
      "occurred_at": "2026-02-05 05:36:24.601855",
      "payload": {
        "nct_id": "NCT06285318",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:24.588129",
      "occurred_at": "2026-02-05 05:36:24.588129",
      "payload": {
        "nct_id": "NCT06208150",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 05:36:24.568269",
      "occurred_at": "2026-02-05 05:36:24.568269",
      "payload": {
        "nct_id": "NCT05972135",
        "linked_assets": 2
      }
    },
    {
      "event_type": "pipeline_ingested",
      "created_at": "2026-02-05 05:36:20.805568",
      "occurred_at": "2026-02-05 05:36:20.805568",
      "payload": {
        "as_of_date": null,
        "pdf_url": "https://s203.q4cdn.com/636242992/files/doc_financials/2025/q4/JNJ-Pipeline-4Q25.pdf",
        "assets_seen": 41
      }
    },
    {
      "event_type": "asset_indication_removed",
      "created_at": "2026-02-05 05:36:20.666840",
      "occurred_at": "2026-02-05 05:36:20.666840",
      "payload": {
        "asset": "RYBREVANT",
        "indication": "Frontline Non Small",
        "stage": "Phase 3",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "asset_indication_removed",
      "created_at": "2026-02-05 05:36:20.664345",
      "occurred_at": "2026-02-05 05:36:20.664345",
      "payload": {
        "asset": "RYBREVANT",
        "indication": "Colorectal Cancer",
        "stage": "Phase 3",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "asset_indication_added",
      "created_at": "2026-02-05 05:36:20.660292",
      "occurred_at": "2026-02-05 05:36:20.660292",
      "payload": {
        "asset": "RYBREVANT",
        "indication": "Head and Neck",
        "stage": "Phase 1",
        "therapeutic_area": "Oncology"
      }
    },
    {
      "event_type": "trials_ingested",
      "created_at": "2026-02-04 21:41:46.960788",
      "occurred_at": "2026-02-04 21:41:46.960788",
      "payload": {
        "trials_seen": 257,
        "inserted": 3,
        "updated": 254,
        "status_changed": 0,
        "bad_aliases": 0
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:45.615989",
      "occurred_at": "2026-02-04 21:41:45.615989",
      "payload": {
        "nct_id": "NCT05567185",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:45.593632",
      "occurred_at": "2026-02-04 21:41:45.593632",
      "payload": {
        "nct_id": "NCT06919965",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:45.579091",
      "occurred_at": "2026-02-04 21:41:45.579091",
      "payload": {
        "nct_id": "NCT06319820",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-04 21:41:45.165853",
      "occurred_at": "2026-02-04 21:41:45.165853",
      "payload": {
        "nct_id": "NCT07194070",
        "title": "Global Prospective Hemolytic Disease of the Fetus and Newborn Registry"
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:33.854107",
      "occurred_at": "2026-02-04 21:41:33.854107",
      "payload": {
        "nct_id": "NCT04150887",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-04 21:41:33.844218",
      "occurred_at": "2026-02-04 21:41:33.844218",
      "payload": {
        "nct_id": "NCT04150887",
        "title": "An Open-label, Multicenter, Phase 1b Study of OV-1001 (Cusatuzumab; Anti-CD70 Monoclonal Antibody) in Combination With Background Therapy for the Treatment of Subjects With Acute Myeloid Leukemia"
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:33.385659",
      "occurred_at": "2026-02-04 21:41:33.385659",
      "payload": {
        "nct_id": "NCT04023526",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-04 21:41:33.375138",
      "occurred_at": "2026-02-04 21:41:33.375138",
      "payload": {
        "nct_id": "NCT04023526",
        "title": "A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy"
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:32.442221",
      "occurred_at": "2026-02-04 21:41:32.442221",
      "payload": {
        "nct_id": "NCT04883619",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:32.428573",
      "occurred_at": "2026-02-04 21:41:32.428573",
      "payload": {
        "nct_id": "NCT06533098",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:32.415105",
      "occurred_at": "2026-02-04 21:41:32.415105",
      "payload": {
        "nct_id": "NCT06449651",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:32.402416",
      "occurred_at": "2026-02-04 21:41:32.402416",
      "payload": {
        "nct_id": "NCT05379634",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:32.389244",
      "occurred_at": "2026-02-04 21:41:32.389244",
      "payload": {
        "nct_id": "NCT05327114",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:32.375434",
      "occurred_at": "2026-02-04 21:41:32.375434",
      "payload": {
        "nct_id": "NCT04119050",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:31.300254",
      "occurred_at": "2026-02-04 21:41:31.300254",
      "payload": {
        "nct_id": "NCT06878404",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:31.284795",
      "occurred_at": "2026-02-04 21:41:31.284795",
      "payload": {
        "nct_id": "NCT06807424",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.987138",
      "occurred_at": "2026-02-04 21:41:29.987138",
      "payload": {
        "nct_id": "NCT03767075",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.973311",
      "occurred_at": "2026-02-04 21:41:29.973311",
      "payload": {
        "nct_id": "NCT06816992",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.960358",
      "occurred_at": "2026-02-04 21:41:29.960358",
      "payload": {
        "nct_id": "NCT06632236",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.948134",
      "occurred_at": "2026-02-04 21:41:29.948134",
      "payload": {
        "nct_id": "NCT07062354",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.935268",
      "occurred_at": "2026-02-04 21:41:29.935268",
      "payload": {
        "nct_id": "NCT05117931",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.923739",
      "occurred_at": "2026-02-04 21:41:29.923739",
      "payload": {
        "nct_id": "NCT05299125",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.910895",
      "occurred_at": "2026-02-04 21:41:29.910895",
      "payload": {
        "nct_id": "NCT04988295",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.886495",
      "occurred_at": "2026-02-04 21:41:29.886495",
      "payload": {
        "nct_id": "NCT04077463",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.862291",
      "occurred_at": "2026-02-04 21:41:29.862291",
      "payload": {
        "nct_id": "NCT05845671",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.847247",
      "occurred_at": "2026-02-04 21:41:29.847247",
      "payload": {
        "nct_id": "NCT06385080",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.832677",
      "occurred_at": "2026-02-04 21:41:29.832677",
      "payload": {
        "nct_id": "NCT06667076",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.815348",
      "occurred_at": "2026-02-04 21:41:29.815348",
      "payload": {
        "nct_id": "NCT06750094",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.797506",
      "occurred_at": "2026-02-04 21:41:29.797506",
      "payload": {
        "nct_id": "NCT06120140",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.778102",
      "occurred_at": "2026-02-04 21:41:29.778102",
      "payload": {
        "nct_id": "NCT06532032",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.755952",
      "occurred_at": "2026-02-04 21:41:29.755952",
      "payload": {
        "nct_id": "NCT05498428",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.739657",
      "occurred_at": "2026-02-04 21:41:29.739657",
      "payload": {
        "nct_id": "NCT06662786",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-04 21:41:29.722081",
      "occurred_at": "2026-02-04 21:41:29.722081",
      "payload": {
        "nct_id": "NCT05488314",
        "linked_assets": 1
      }
    }
  ],
  "trials": [
    {
      "nct_id": "NCT04083976",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-04",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04119050",
      "overall_status": "RECRUITING",
      "phase": "PHASE2,PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "nipocalimab"
      ]
    },
    {
      "nct_id": "NCT04538664",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "(amivantamab)"
      ]
    },
    {
      "nct_id": "NCT05663866",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "(amivantamab)"
      ]
    },
    {
      "nct_id": "NCT04487080",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "(amivantamab)"
      ]
    },
    {
      "nct_id": "NCT04181827",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04882098",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT04936308",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT04325828",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "ERLEADA"
      ]
    },
    {
      "nct_id": "NCT04108208",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE4",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "ERLEADA"
      ]
    },
    {
      "nct_id": "NCT04113018",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-03",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06066346",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-03",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05388669",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "(amivantamab)"
      ]
    },
    {
      "nct_id": "NCT03390504",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03462719",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03901963",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06266663",
      "overall_status": "RECRUITING",
      "phase": null,
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03596645",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03451851",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT04033445",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2,PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT03466411",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2,PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "STELARA",
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT03301220",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-30",
      "linked_assets": []
    },
    {
      "nct_id": "NCT02365597",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-30",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03881098",
      "overall_status": "RECRUITING",
      "phase": "NA",
      "last_update_posted": "2026-01-29",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06319820",
      "overall_status": "RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-27",
      "linked_assets": [
        "INLEXZO (gemcitabine"
      ]
    },
    {
      "nct_id": "NCT04557098",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-27",
      "linked_assets": [
        "TECVAYLI"
      ]
    },
    {
      "nct_id": "NCT05421663",
      "overall_status": "RECRUITING",
      "phase": "PHASE1,PHASE2",
      "last_update_posted": "2026-01-27",
      "linked_assets": [
        "JNJ-1900",
        "autoleucel"
      ]
    },
    {
      "nct_id": "NCT05289687",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-26",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06193863",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-23",
      "linked_assets": []
    },
    {
      "nct_id": "NCT07245394",
      "overall_status": "RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-23",
      "linked_assets": [
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT05316155",
      "overall_status": "RECRUITING",
      "phase": "PHASE1,PHASE2",
      "last_update_posted": "2026-01-22",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05601973",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-21",
      "linked_assets": [
        "(amivantamab)"
      ]
    },
    {
      "nct_id": "NCT05900388",
      "overall_status": "NOT_YET_RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-21",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04933539",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-20",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03652064",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-20",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06220604",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-20",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04267887",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-20",
      "linked_assets": [
        "ERLEADA",
        "actorXla"
      ]
    },
    {
      "nct_id": "NCT05972135",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-20",
      "linked_assets": [
        "TALVEY + TECVAYLI",
        "TECVAYLI"
      ]
    },
    {
      "nct_id": "NCT07194070",
      "overall_status": "RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT02354014",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": [
        "RYBREVANT"
      ]
    },
    {
      "nct_id": "NCT06768489",
      "overall_status": "RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06604715",
      "overall_status": "RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05652335",
      "overall_status": "RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05455320",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT07266441",
      "overall_status": "NOT_YET_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05050097",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06500884",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04634552",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05160584",
      "overall_status": "RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03399799",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    }
  ]
}